in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

the senate will "hopefully" take up the tobacco bill in june, lewis told the news service. the last day of formal sessions this year is july 31..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).., seventh-highest in the nation, and more than double the national average.